scorecardresearchDiagnostics sector may see a de-rating, sell Dr. Lal PathLabs, Metropolis Healthcare, says Antique Broking

Diagnostics sector may see a de-rating, sell Dr. Lal PathLabs, Metropolis Healthcare, says Antique Broking

Updated: 07 Sep 2022, 10:30 AM IST
TL;DR.
  • Antique said a closer look at diagnostics companies suggests that growth per patient realization is going to remain under pressure for a considerable future.
Diagnostic companies have resorted to the asset-light model in order to grow faster.

Diagnostic companies have resorted to the asset-light model in order to grow faster.